Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant
NCT05405387
Age 18 +
Sex Both
Phase Phase 2
Third Opinion Trial Synopsis
This study is about testing a medicine called budesonide on people who have multiple myeloma and are getting a certain kind of transplant. The study has two groups: one group tries the medicine, and the other group doesn't. Before the study starts, 20 patients go through a run-in period.
This study is about testing a medicine called budesonide on people who have multiple myeloma and are getting a certain kind of transplant. The study has two groups: one group tries the medicine, and the other group doesn't. Before the study starts, 20 patients go through a run-in period.
Third Opinion AI Generated Synopsis
Trial Summary
A randomized placebo controlled, phase 2 study of budesonide in subjects with multiple myeloma undergoing autologous stem cell transplant (ACST). The study includes a run-in period with 20 patients.
A randomized placebo controlled, phase 2 study of budesonide in subjects with multiple myeloma undergoing autologous stem cell transplant (ACST). The study includes a run-in period with 20 patients.
from ClinicalTrials.gov
Locations & Contact
Fill out the form and to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts:
